Innovating Works

QVQ BV

Desconocido
ONCORNET2.0: ONCOgenic Receptor Network of Excellence and Training 2.0 QVQ HOLDING BV participó en un H2020: H2020-MSCA-ITN-2019 Cancer is a major health burden responsible for 20% of European deaths. There is a critical need to understand its fundamental biological me...
2019-08-27 - 2024-01-31 | Financiado
OPATHY: From Omics to Patient Improving Diagnostics of Pathogenic Yeasts QVQ HOLDING BV participó en un H2020: H2020-MSCA-ITN-2014 OPATHY is an innovative translational research training network that will explore the potential of omics technologies, including genomics, t...
2015-08-18 - 2019-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.